Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 59.30
0.00 (0.00%)
At close: Feb 11, 2026
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 2.36 billion as of February 13, 2026. Its market cap has decreased by -4.07% in one year.
Market Cap
2.36B
Enterprise Value
2.40B
Revenue
698.11M
Ranking
n/a
PE Ratio
66.83
Stock Price
59.30
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has increased from 1.68B to 2.36B, an increase of 40.23%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.36B | -5.87% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Optoelectronics | 3.26B |
| Medimaging Integrated Solution | 3.25B |
| WeLeader Biomedical | 3.23B |
| A Plus Biotechnology | 2.82B |
| Applied BioCode | 2.47B |
| Dynamic Medical Technologies | 2.37B |
| Wellell | 2.33B |
| OK Biotech | 2.00B |